What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Cancer
- Gene
Her primary scientific interests are in Internal medicine, Endocrinology, Pathology, Thyroid and Thyroid carcinoma.
Her work in Endocrinology addresses subjects such as Gene expression, which are connected to disciplines such as Fibroblast growth factor and Transgene.
Her studies in Pathology integrate themes in fields like Cancer and Pituitary tumorigenesis.
Her Thyroid research is multidisciplinary, relying on both Follicular phase and Adenocarcinoma.
Sylvia L. Asa studied Adenocarcinoma and Cell adhesion molecule that intersect with Cancer research.
Her Thyroid carcinoma study combines topics in areas such as Gene rearrangement, Carcinoma, MEDLINE and Thyroidectomy.
Her most cited work include:
- Integrated Genomic Characterization of Papillary Thyroid Carcinoma (1453 citations)
- Revised American thyroid association guidelines for the management of medullary thyroid carcinoma (961 citations)
- The prevalence of pituitary adenomas: a systematic review. (863 citations)
What are the main themes of her work throughout her whole career to date?
Her primary areas of study are Pathology, Internal medicine, Endocrinology, Thyroid and Immunohistochemistry.
Pathology and Thyroid carcinoma are frequently intertwined in her study.
Her Internal medicine study frequently intersects with other fields, such as Oncology.
The study of Endocrinology is intertwined with the study of Gene expression in a number of ways.
Sylvia L. Asa has researched Thyroid in several fields, including Cancer, Adenocarcinoma and Malignancy.
Her Pituitary tumors research focuses on subjects like Cancer research, which are linked to DNA methylation, Epigenetics and Carcinogenesis.
She most often published in these fields:
- Pathology (62.86%)
- Internal medicine (41.38%)
- Endocrinology (36.74%)
What were the highlights of her more recent work (between 2017-2021)?
- Pathology (62.86%)
- Thyroid (28.91%)
- Neuroendocrine tumors (8.49%)
In recent papers she was focusing on the following fields of study:
Sylvia L. Asa mainly focuses on Pathology, Thyroid, Neuroendocrine tumors, Immunohistochemistry and Internal medicine.
Her work in Pathology tackles topics such as Corticotropic cell which are related to areas like Pituitary tumors and Null cell.
Thyroid carcinoma and Thyroid cancer are subfields of Thyroid in which her conducts study.
Her study on Neuroendocrine tumors also encompasses disciplines like
- Hormone which intersects with area such as Bioinformatics,
- Cancer research which intersects with area such as Epigenetics, Molecular pathology and Adenoma.
Her research integrates issues of Cell type and Pathogenesis in her study of Immunohistochemistry.
Sylvia L. Asa combines subjects such as Gastroenterology, Endocrinology, Oncology and SDHB with her study of Internal medicine.
Between 2017 and 2021, her most popular works were:
- Pan-cancer analysis of whole genomes (751 citations)
- Genomic and Functional Approaches to Understanding Cancer Aneuploidy (368 citations)
- A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. (341 citations)
In her most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
Sylvia L. Asa spends much of her time researching Pathology, Thyroid, Neuroendocrine tumors, Immunohistochemistry and Cancer research.
Her Pathology research is multidisciplinary, incorporating elements of Hormone, Somatotropic cell and Endocrine pathology.
The Thyroid study combines topics in areas such as Cyst and Malignancy.
Her work deals with themes such as Oncogene, Transcription factor, Chromatin, microRNA and PTEN, which intersect with Cancer research.
Her research on Acromegaly concerns the broader Endocrinology.
Her Tumor progression study deals with the bigger picture of Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
